Header Logo

Connection

JOSEPH LUBEGA to Immunoglobulins, Intravenous

Back to Details
This is a "connection" page, showing publications JOSEPH LUBEGA has written about Immunoglobulins, Intravenous.
JOSEPH LUBEGA
Connection Strength
0.043
Immunoglobulins, Intravenous
  1. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.